부산대학교 도서관

Rosenberg SM; 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Greaney ML; 2Department of Kinesiology, University of Rhode Island, Kingston, Rhode Island.; Patenaude AF; 3Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts.; Partridge AH; 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101543508 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2156-535X (Electronic) Linking ISSN: 21565333 NLM ISO Abbreviation: J Adolesc Young Adult Oncol Subsets: MEDLINE

Sepucha KR; Division of General Internal Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Langford AT; Division of Comparative Effectiveness and Decision Science, Department of Population Health, NYU School of Medicine, New York, NY, USA.; Belkora JK; University of California at San Francisco, San Francisco, CA, USA.; Chang Y; Division of General Internal Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Moy B; Division of Hematology/Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Partridge AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Lee CN; The Ohio State University, Columbus, OH, USA.

Publisher: Sage Publications Country of Publication: United States NLM ID: 8109073 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-681X (Electronic) Linking ISSN: 0272989X NLM ISO Abbreviation: Med Decis Making Subsets: MEDLINE

Bellon JR; Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, 450 Brookline Avenue, Boston, MA, USA. Jennifer_bellon@dfci.harvard.edu.; Guo H; Department of Statistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Barry WT; Department of Statistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Dang CT; Breast Cancer Medicine Service, Solid Tumor Division, Department of Medicine, Memorial Sloan Kettering Cancer Center and Department of Medicine, Weill Cornell Medical Center, New York, NY, USA.; Yardley DA; Department of Medical Oncology, Sarah Cannon Cancer Center, Nashville, TN, USA.; Moy B; Department of Hematology-Oncology, Massachusetts General Hospital, Boston, MA, USA.; Marcom PK; Division of Medical Oncology, Department of Medicine, Duke Cancer Institute, Durham, NC, USA.; Albain KS; Division of Hematology/Oncology, Department of Medicine, Cardinal Bernardin Cancer Center, Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA.; Rugo HS; Department of Medicine, Division of Oncology, Helen Diller Comprehensive Cancer Center, University of California, San Francisco, CA, USA.; Ellis M; Department of Medical Oncology, Baylor Clinic-Lester and Sue Smith Breast Center, Houston, TX, USA.; Wolff AC; Department of Oncology, Johns Hopkins Kimmel Cancer Center, Baltimore, MD, USA.; Carey LA; Department of Medical Oncology, UNC Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.; Overmoyer BA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Partridge AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Hudis CA; Breast Cancer Medicine Service, Solid Tumor Division, Department of Medicine, Memorial Sloan Kettering Cancer Center and Department of Medicine, Weill Cornell Medical Center, New York, NY, USA.; American Society of Clinical Oncology, Alexandria, VA, USA.; Krop I; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Burstein HJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Winer EP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Tolaney SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

Zhou ES; Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.; Harvard Medical School, 25 Shattuck Street, Boston, MA, USA.; Hall KT; Harvard Medical School, 25 Shattuck Street, Boston, MA, USA.; Brigham and Women's Hospital, 900 Commonwealth Avenue, Boston, MA, USA.; Michaud AL; Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.; Blackmon JE; Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.; Partridge AH; Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.; Harvard Medical School, 25 Shattuck Street, Boston, MA, USA.; Recklitis CJ; Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. christopher_recklitis@dfci.harvard.edu.; Harvard Medical School, 25 Shattuck Street, Boston, MA, USA. christopher_recklitis@dfci.harvard.edu.

Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1433-7339 (Electronic) Linking ISSN: 09414355 NLM ISO Abbreviation: Support Care Cancer Subsets: MEDLINE

Partridge AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Harvard University, Boston, Massachusetts.; Ruddy KJ; Department of Oncology, Mayo Clinic, Rochester, Minnesota.; Barry WT; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Harvard University, Boston, Massachusetts.; Greaney ML; Department of Kinesiology, University of Rhode Island at Kingston, Kingston, Rhode Island.; Ligibel JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Harvard University, Boston, Massachusetts.; Sprunck-Harrild KM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Rosenberg SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Harvard University, Boston, Massachusetts.; Baker EL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Hoverman JR; Texas Oncology PA, Austin, Texas.; Emmons KM; Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts.

Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

Rath M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America.; Li Q; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America.; National Engineering Research Center for Biochip, Shanghai Biochip Limited Corporation, Shanghai, China.; Li H; National Engineering Research Center for Biochip, Shanghai Biochip Limited Corporation, Shanghai, China.; Lindström S; Department of Epidemiology, University of Washington, Seattle, United States of America.; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, United States of America.; Miron A; Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, United States of America.; Miron P; Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, United States of America.; Dowton AE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America.; Meyer ME; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America.; Larson BG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America.; Pomerantz M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America.; Seo JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America.; Collins LC; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, United States of America.; Vardeh H; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, United States of America.; Brachtel E; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, United States of America.; Come SE; Beth Israel Deaconess Medical Center, Boston, United States of America.; Borges V; University of Colorado Denver, Aurora, United States of America.; Schapira L; Stanford University Medical Center, Palo Alto, United States of America.; Tamimi RM; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, United States of America.; Partridge AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America.; Freedman M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America.; Ruddy KJ; Department of Oncology, Mayo Clinic, Rochester, United States of America.

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

von Hippel C; Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.; Rosenberg SM; Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Austin SB; Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Sprunck-Harrild K; Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Ruddy KJ; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota.; Schapira L; Division of Medical Oncology, Stanford University Medical Center, Stanford, California.; Come S; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Breast Cancer Program, Beth Israel Deaconess Medical Center, Boston, Massachusetts.; Borges VF; Division of Medical Oncology, University of Colorado Denver, Aurora, Colorado.; Partridge AH; Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.

Publisher: Wiley Country of Publication: England NLM ID: 9214524 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1099-1611 (Electronic) Linking ISSN: 10579249 NLM ISO Abbreviation: Psychooncology Subsets: MEDLINE

Lambertini M; Department of Medical Oncology, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy. Electronic address: matteo.lambertini@unige.it.; Di Maio M; Medical Oncology, A.O. Ordine Mauriziano, Department of Oncology, University of Turin, Turin, Italy.; Poggio F; Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, IRCCS Ospedale Policlinico San Martino, Genova, Italy.; Pagani O; Breast Unit and Institute of Oncology of Southern Switzerland, Geneva University Hospitals, Swiss Group for Clinical Cancer Research, Lugano Viganello, Switzerland.; Curigliano G; University of Milan, Department of Oncology and Hemato-Oncology, New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, European School of Oncology, Milan, Italy.; Mastro LD; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy; Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, IRCCS Ospedale Policlinico San Martino, Genova, Italy.; Paluch-Shimon S; Department of Oncology, Shaare Zedek Medical Centre, Jerusalem, Israel.; Loibl S; German Breast Group, Neu-Isenburg, and Centre for Haematology and Oncology, Frankfurt, Germany.; Partridge AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Azim HA Jr; Department of Medicine, Division of Hematology/Oncology, American University of Beirut, Beirut, Lebanon.; Peccatori FA; Fertility and Procreation Unit, Gynecologic Oncology Department, European Institute of Oncology IRCCS, European School of Oncology, Milan, Italy.; Demeestere I; Fertility Clinic, Research Laboratory on Human Reproduction, CUB-Erasme and Université Libre de Bruxelles, Brussels, Belgium.

Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101122473 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1472-6491 (Electronic) Linking ISSN: 14726483 NLM ISO Abbreviation: Reprod Biomed Online Subsets: MEDLINE

Matias M; Department of Medical Oncology, Gustave Roussy, Université Paris-Sud, Université Paris-Saclay, Villejuif, France.; Baciarello G; Department of Medical Oncology, Gustave Roussy, Université Paris-Sud, Université Paris-Saclay, Villejuif, France.; Neji M; Department of Medical Oncology, Gustave Roussy, Université Paris-Sud, Université Paris-Saclay, Villejuif, France.; Departement of Medical Oncology, Centre Hospitalier Intercommunal de Créteil, Créteil, France.; Di Meglio A; INSERM UMR 981, Gustave Roussy, Villejuif, France.; Michiels S; Department of Biostatistics and Epidemiology, Gustave Roussy, Université Paris-Sud, University Paris-Saclay, Villejuif, France.; Partridge AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Bendiane MK; Provence-Alpes-Côte d'Azur Regional Health Observatory, INSERM UMR912, Marseille, France.; Fizazi K; Department of Medical Oncology, Gustave Roussy, Université Paris-Sud, Université Paris-Saclay, Villejuif, France.; Ducreux M; Department of Medical Oncology, Gustave Roussy, Université Paris-Sud, Université Paris-Saclay, Villejuif, France.; Andre F; Department of Medical Oncology, Gustave Roussy, Université Paris-Sud, Université Paris-Saclay, Villejuif, France.; INSERM UMR 981, Gustave Roussy, Villejuif, France.; Vaz-Luis I; Department of Medical Oncology, Gustave Roussy, Université Paris-Sud, Université Paris-Saclay, Villejuif, France.; INSERM UMR 981, Gustave Roussy, Villejuif, France.

Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE

Sella T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Partridge AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. ann_partridge@dfci.harvard.edu.

Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol